JP2018530566A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018530566A5 JP2018530566A5 JP2018517867A JP2018517867A JP2018530566A5 JP 2018530566 A5 JP2018530566 A5 JP 2018530566A5 JP 2018517867 A JP2018517867 A JP 2018517867A JP 2018517867 A JP2018517867 A JP 2018517867A JP 2018530566 A5 JP2018530566 A5 JP 2018530566A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- linagliptin
- tablets
- polymorphic form
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15189208 | 2015-10-09 | ||
| EP15189208.0 | 2015-10-09 | ||
| PCT/EP2016/073952 WO2017060398A1 (en) | 2015-10-09 | 2016-10-07 | Pharmaceutical composition containing 8-[(3r)-3-amino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[4-methyl-2-quinazolinyl)methyl]-1h-purine-2,6-dione or a pharmaceutically acceptable salt thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018530566A JP2018530566A (ja) | 2018-10-18 |
| JP2018530566A5 true JP2018530566A5 (OSRAM) | 2019-11-07 |
| JP6839708B2 JP6839708B2 (ja) | 2021-03-10 |
Family
ID=54293102
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018517867A Expired - Fee Related JP6839708B2 (ja) | 2015-10-09 | 2016-10-07 | ８−［（３ｒ）−３−アミノ−１−ピペリジニル］−７−（２−ブチン−１−イル）−３，７−ジヒドロ−３−メチル−１−［４−メチル−２−キナゾリニル）メチル］−１ｈ−プリン−２，６−ジオンまたは薬学上許容できるその塩を含有する医薬組成物 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US10668073B2 (OSRAM) |
| EP (1) | EP3359136A1 (OSRAM) |
| JP (1) | JP6839708B2 (OSRAM) |
| CN (1) | CN108174596A (OSRAM) |
| AU (1) | AU2016335082A1 (OSRAM) |
| CA (1) | CA2998982A1 (OSRAM) |
| EA (1) | EA037498B1 (OSRAM) |
| WO (1) | WO2017060398A1 (OSRAM) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020009675A2 (en) | 2018-06-01 | 2020-01-09 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Solid oral pharmaceutical compositions of linagliptin |
| CN110496129B (zh) * | 2018-11-23 | 2021-06-04 | 北京中医药大学 | 利拉利汀的抗肿瘤活性及其新用途 |
| JP7245694B2 (ja) * | 2019-03-26 | 2023-03-24 | エルメッド株式会社 | リナグリプチン含有医薬組成物及びその製造方法、並びにリナグリプチン含有医薬組成物の品質の向上方法 |
| JPWO2022102457A1 (OSRAM) * | 2020-11-10 | 2022-05-19 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1532149T3 (da) | 2002-08-21 | 2010-05-10 | Boehringer Ingelheim Pharma | 8-[3-amino-piperiden-1-yl]-xanthiner, fremstilling deraf og anvendelse deraf som lægemiddel |
| MX2008014024A (es) | 2006-05-04 | 2008-11-14 | Boehringer Ingelheim Int | Formas poliformas. |
| EP1852108A1 (en) * | 2006-05-04 | 2007-11-07 | Boehringer Ingelheim Pharma GmbH & Co.KG | DPP IV inhibitor formulations |
| EP2382216A1 (en) | 2008-12-23 | 2011-11-02 | Boehringer Ingelheim International GmbH | Salt forms of organic compound |
| US20120258170A1 (en) * | 2009-05-20 | 2012-10-11 | Nutracryst Therapeutics Private Limited | Pharmaceutical co-crystals of quercetin |
| EP2707368B1 (en) | 2011-05-10 | 2016-02-03 | Sandoz AG | Polymorph of linagliptin benzoate |
| CN103006663A (zh) * | 2011-09-23 | 2013-04-03 | 重庆药友制药有限责任公司 | 一种瑞舒伐他汀钙的药物组合物 |
| CN102631331A (zh) * | 2012-04-26 | 2012-08-15 | 北京哈三联科技股份有限公司 | 奥氮平口腔崩解片制剂及其制备方法 |
| EP3311803A1 (en) | 2012-08-13 | 2018-04-25 | Sandoz AG | Stable pharmaceutical composition containing 8-[(3r)-3-amino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1h-purine-2,6-dione or a pharmaceutically acceptable salt thereof |
| WO2014193528A1 (en) * | 2013-04-29 | 2014-12-04 | Anovel Pharmaceuticals, Llc | Amorphous dosage forms and methods |
| EP2996678A1 (en) * | 2013-05-16 | 2016-03-23 | Sandoz AG | Tablet with increased drug load of odanacatib |
| EP2848242A1 (en) * | 2013-09-12 | 2015-03-18 | Sanovel Ilac Sanayi ve Ticaret A.S. | Orally disintegrating formulations of Linagliptin |
-
2016
- 2016-10-07 JP JP2018517867A patent/JP6839708B2/ja not_active Expired - Fee Related
- 2016-10-07 AU AU2016335082A patent/AU2016335082A1/en not_active Abandoned
- 2016-10-07 CN CN201680058418.5A patent/CN108174596A/zh active Pending
- 2016-10-07 EA EA201890744A patent/EA037498B1/ru unknown
- 2016-10-07 US US15/767,131 patent/US10668073B2/en not_active Expired - Fee Related
- 2016-10-07 EP EP16778023.8A patent/EP3359136A1/en not_active Withdrawn
- 2016-10-07 CA CA2998982A patent/CA2998982A1/en not_active Abandoned
- 2016-10-07 WO PCT/EP2016/073952 patent/WO2017060398A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL275982B1 (en) | Pharmaceutical compositions for treating cystic fibrosis | |
| JP2009537538A5 (OSRAM) | ||
| CA2483199A1 (en) | High drug load tablet of imatinib | |
| JP2018530566A5 (OSRAM) | ||
| CN104220068A (zh) | 包含奥美沙坦酯和罗苏伐他汀或其盐的药物组合物 | |
| FI4029498T3 (fi) | Bis-koliinitetratiomolybdaatti wilsonin taudin hoitoa varten | |
| JP2020511419A5 (OSRAM) | ||
| JP2016530238A5 (OSRAM) | ||
| RU2015117523A (ru) | Комбинированный препарат, содержащий гемиглиптин и метформин, и способ его получения | |
| RU2016106336A (ru) | Противотуберкулезная композиция, содержащая рифампицин, изониазид, этамбутол и пиразинамид, и способ ее получения | |
| RU2011134964A (ru) | Фармацевтическая композиция, содержащая алеглитазар | |
| JP2018530566A (ja) | ８−［（３ｒ）−３−アミノ−１−ピペリジニル］−７−（２−ブチン−１−イル）−３，７−ジヒドロ−３−メチル−１−［４−メチル−２−キナゾリニル）メチル］−１ｈ−プリン−２，６−ジオンまたは薬学上許容できるその塩を含有する医薬組成物 | |
| JP7226697B2 (ja) | ブロナンセリン含有錠剤 | |
| US20110104267A1 (en) | Pharmaceutical compositions of antiretrovirals | |
| RU2018128416A (ru) | Способ получения фармацевтической композиции, включающей производное хинолина или его соль | |
| JP2018172359A (ja) | 適量のビニルピロリドンの重合体を含む、エゼチミブ含有錠剤 | |
| WO2011161689A1 (en) | Imatinib mesilate pharmaceutical tablet | |
| WO2013169218A1 (en) | Pharmaceutical compositions of s-etodolac | |
| CA2517372A1 (en) | Pharmaceutical composition of alendronic acid, salts or esters thereof, and a process for its preparation | |
| JP2018184381A (ja) | エゼチミブ含有錠剤およびその製法 | |
| US20160143923A1 (en) | Low dose pharmaceutical composition of doxycycline | |
| WO2013154512A1 (en) | Pharmaceutical formulations comprising dexibuprofen | |
| RU2021125201A (ru) | Готовая фармацевтическая лекарственная форма соли метенамина, такой как метенамина манделат | |
| FI3843702T3 (fi) | Memantiinin ja donepetsiilin välittömästi vapauttava vakioannoksinen yhdistelmä | |
| RU2025107342A (ru) | Пероральная фармацевтическая форма немедленного высвобождения амлодипина с увеличенным содержанием api |